ArticleBMC infectious diseases2014
Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.
Chawangwa Modongo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this paperpooled itcites it